1 2 3 

NEXT

DeltaZorb Nutrient Absorption Technology 
Technical Research Overview

"[Bioavailability enhancement] has legitimate application in the filed of nutrition, particularly since we are becoming increasingly aware of the impact of dietary shortfalls in our health."¹

The powerful properties of DeltaZorb™ active ingredients were measured in several volunteer clinical studies conducted within the United States. Categories evaluated included fat-soluble (in the form of beta-carotene) water-soluble, (in the form of vitamin B₆) and minerals, (in the form of selenomethionine or selenium). Gastrointestinal absorption of all studied nutrients, as measured by amounts present in blood after ingestion, increased dramatically — to up to 160% — when DeltaZorb™ active ingredients were used.

DeltaZorb™* active ingredients act as nutrient bioenhancers, allowing the digestive system to absorb nutrients from food and nutritional supplements more effectively and completely. Researchers conducted several tests confirming the validity and efficacy of these ingredients.

Test 1. - Bioavailability of Beta-carotene combined with DeltaZorb™ Active Ingredients²

This study was a pioneering effort to evaluate the potential of DeltaZorb™ active ingredients to change the oral bioavailability of a nutrient, namely Beta-carotene, a fat soluble vitamin precursor. Twelve adult male volunteers were selected for a crossover absorption study. The subjects, aged 22-43 years, were in good health, nonsmoking and did not consume alcohol.

The subjects were randomly assigned into two groups of six subjects each. All subjects stayed on their self-selected diets. They were instructed not to change their eating habits. Each day of the study, half the volunteers received a soft-gel capsule containing 15-mg beta-carotene per capsule along with a two piece, hard-shell capsule containing DeltaZorb™ active ingredients. The other half received the same beta-carotene soft-gel capsule daily plus a two piece, hard-shell placebo capsule. Daily baseline blood samples were taken previous to the supplement’s ingestion. In addition, on days 2, 4, 7, 10 and 14, fasting blood samples were collected for serum beta-carotene analysis.

After completion of the first study period, the subjects returned to their regular lifestyles for the next three months. After this period, the subjects were tested following an overnight fast to determine their baseline of B-carotene levels. Subsequently, they repeated the first study protocol with crossover between participants previously receiving the active treatment with participants receiving the placebo treatment.

The average baseline beta-carotene values were evaluated in both study periods, and did not differ significantly between the volunteers. However, the change in beta-carotene values from baseline to day 14 was significantly greater for the active study compared to the placebo study.

NEXT